Submit Article

Several companies worldwide claim to possess the required expertise and infrastructure to offer contract manufacturing services

Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.

 

 

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to continue relying on contract service providers for various aspects of antibody-based product development and manufacturing.

 

 

An estimate of the overall, installed capacity for manufacturing antibodies based on data reported by industry stakeholders in the public domain; it highlights the distribution of available antibody production capacity on the basis of company size (small, mid-sized, large and very large firms), scale of operation (preclinical, clinical and commercial), and key geographical regions (North America, Europe, Asia).

 

 

Over 100 CMOs presently claim to offer manufacturing services for antibodies

The antibody contract manufacturing market size is currently dominated by the presence of small and mid-sized companies, which represent 70% of the industry stakeholders. It is also worth highlighting that more than 55% of CMOs claim to have the capabilities to manufacture antibodies across all scales of operation (preclinical, clinical and commercial).

 

More than 90% service providers are focused on the production of monoclonal antibodies

However, players based in Asia are now increasingly focusing on the development of bispecific antibodies for therapeutic use. It worth highlighting that close to 20% of the CMOs engaged in this domain claim to offer manufacturing services for both bispecific antibodies and antibody fragments.

 

 

To request a sample copy / brochure of this report, please visit this– https://www.rootsanalysis.com/reports/295/request-sample.html

 

The USD 17 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:

  • Type of Antibodies
  • Monoclonal Antibodies
  • Bispecific Antibodies
  • ADCs
  • Others

 

  • Company Size
  • Small
  • Mid-sized
  • Large / Very Large

 

  • Scale of Operation
  • Preclinical / Clinical
  • Commercial

 

  • Type of expression system used
  • Mammalian
  • Microbial

 

  • Key geographical regions
  • North America
  • Europe
  • Asia and RoW

 

The Antibody Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 

  • AGC Biologics
  • Aldevron
  • AMRI
  • Boehringer Ingelheim BioXcellence
  • Emergent BioSolutions
  • Eurofins CDMO
  • FUJIFILM Diosynth Biotechnologies
  • KBI Biopharma
  • Lonza
  • Nitto Avecia Pharma Services
  • Novasep
  • Pierre Fabre
  • Samsung BioLogics
  • Synthon
  • Thermo Fisher Scientific

 

Table of Contents

 

  1. Preface

 

  1. Executive Summary

 

  1. Introduction

 

  1. Market Landscape

 

  1. Company Competitive Analysis

 

  1. Company Profiles

 

  1. Case Study: Comparison of Small and Large Molecules (Biologics) Drugs / Therapies

 

  1. Benchmark Analysis

 

  1. Partnerships

 

  1. Recent Expansions

 

  1. Capacity Analysis

 

  1. Demand Analysis

 

  1. Market Sizing and Opportunity Analysis

 

  1. SWOT Analysis

 

  1. Future of The Antibody CMO Market

 

  1. Interview Transcripts

 

  1. Appendix 1: List of Antibody Custom Manufacturers

 

  1. Appendix 2: Tabulated Data

 

  1. Appendix 3: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

 

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

 

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis

Medium – https://medium.com/@RootsAnalysis

Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/

Quora – https://rootsanalysisinsights.quora.com/

Article Estates
Logo
Shopping cart